{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:58:48Z","timestamp":1783727928151,"version":"3.55.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Hong Kong Research Grants Council","award":["AoE\/M-06\/08"],"award-info":[{"award-number":["AoE\/M-06\/08"]}]},{"name":"Hong Kong Research Grants Council","award":["C7011-15R"],"award-info":[{"award-number":["C7011-15R"]}]},{"name":"Hong Kong Health and Medical Research Fund","award":["HKM-15-M01"],"award-info":[{"award-number":["HKM-15-M01"]}]},{"name":"SK Yee Medical Research Fund"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.virusres.2017.04.019","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T04:01:57Z","timestamp":1493265717000},"page":"296-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR\/Cas9"],"prefix":"10.1016","volume":"244","author":[{"given":"Kit-San","family":"Yuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nok-Hei Mickey","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Qian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsz-Fung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Yin","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Ping","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yan","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2017.04.019_bib0005","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1128\/JVI.61.5.1743-1746.1987","article-title":"Replication of latent Epstein-Barr virus genomes in Raji cells","volume":"61","author":"Adams","year":"1987","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2017.04.019_bib0010","doi-asserted-by":"crossref","first-page":"e1003314","DOI":"10.1371\/journal.ppat.1003314","article-title":"The EBV latent antigen 3C inhibits apoptosis through targeted regulation of interferon regulatory factors 4 and 8","volume":"9","author":"Banerjee","year":"2013","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.virusres.2017.04.019_bib0015","doi-asserted-by":"crossref","first-page":"e1004090","DOI":"10.1371\/journal.ppat.1004090","article-title":"High-efficiency targeted editing of large viral genomes by RNA-guided nucleases","volume":"10","author":"Bi","year":"2014","journal-title":"PLoS Pathog."},{"issue":"7","key":"10.1016\/j.virusres.2017.04.019_bib0020","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1093\/jnci\/dji084","article-title":"Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma","volume":"97","author":"Chan","year":"2005","journal-title":"J. Natl. Cancer Inst."},{"issue":"1","key":"10.1016\/j.virusres.2017.04.019_bib0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/(SICI)1097-0215(19990924)83:1<121::AID-IJC21>3.0.CO;2-F","article-title":"Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus","volume":"83","author":"Cheung","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.virusres.2017.04.019_bib0030","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1084\/jem.20072581","article-title":"An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival","volume":"205","author":"Choy","year":"2008","journal-title":"J. Exp. Med."},{"issue":"6121","key":"10.1016\/j.virusres.2017.04.019_bib0035","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","article-title":"Multiplex genome engineering using CRISPR\/Cas systems","volume":"339","author":"Cong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.virusres.2017.04.019_bib0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2015.03.015","article-title":"Targeting hepatitis B virus cccDNA by CRISPR\/Cas9 nuclease efficiently inhibits viral replication","volume":"118","author":"Dong","year":"2015","journal-title":"Antiviral Res."},{"key":"10.1016\/j.virusres.2017.04.019_bib0045","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1038\/srep02510","article-title":"Harnessing the CRISPR\/Cas9 system to disrupt latent HIV-1 provirus","volume":"3","author":"Ebina","year":"2013","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.virusres.2017.04.019_bib0050","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOL.0b013e3283555a7e","article-title":"Gene therapy for lipoprotein lipase deficiency","volume":"23","author":"Gaudet","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"issue":"2","key":"10.1016\/j.virusres.2017.04.019_bib0055","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jac\/dki240","article-title":"Epstein-Barr virus infections: prospects for treatment","volume":"56","author":"Gershburg","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.virusres.2017.04.019_bib0060","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2013.06.044","article-title":"CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes","volume":"154","author":"Gilbert","year":"2013","journal-title":"Cell"},{"issue":"45","key":"10.1016\/j.virusres.2017.04.019_bib0065","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1038\/onc.2009.258","article-title":"Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints","volume":"28","author":"Gruhne","year":"2009","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.virusres.2017.04.019_bib0070","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/JVI.01999-06","article-title":"Inhibition of heavy chain and \u03b22-microglobulin synthesis as a mechanism of major histocompatibility complex class I downregulation during Epstein-Barr virus replication","volume":"81","author":"Guerreiro-Cacais","year":"2007","journal-title":"J. Virol."},{"issue":"14","key":"10.1016\/j.virusres.2017.04.019_bib0075","doi-asserted-by":"crossref","first-page":"6615","DOI":"10.1128\/JVI.75.14.6615-6624.2001","article-title":"Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors","volume":"75","author":"Halbert","year":"2001","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2017.04.019_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.2910170102","article-title":"Epstein\u2013?Barr virus-specific IgA antibodies as an outstanding feature of nasopharyngeal carcinoma","volume":"17","author":"Henle","year":"1976","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.virusres.2017.04.019_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-005-0036-x","article-title":"Suppression of Epstein-Barr nuclear antigen 1 (EBNA1) by RNA interference inhibits proliferation of EBV-positive Burkitt\u2019s lymphoma cells","volume":"132","author":"Hong","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"31","key":"10.1016\/j.virusres.2017.04.019_bib0090","doi-asserted-by":"crossref","first-page":"11461","DOI":"10.1073\/pnas.1405186111","article-title":"RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection","volume":"111","author":"Hu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virusres.2017.04.019_bib0095","doi-asserted-by":"crossref","first-page":"612823","DOI":"10.1155\/2014\/612823","article-title":"Disruption of HPV16-E7 by CRISPR\/Cas system induces apoptosis and growth inhibition in HPV16 positive human cervical cancer cells","volume":"2014","author":"Hu","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"8","key":"10.1016\/j.virusres.2017.04.019_bib0100","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/ijc.27439","article-title":"Activation of lytic cycle of Epstein-Barr virus by suberoylanilide hydroxamic acid leads to apoptosis and tumor growth suppression of nasopharyngeal carcinoma","volume":"131","author":"Hui","year":"2012","journal-title":"Int. J. Cancer"},{"issue":"1","key":"10.1016\/j.virusres.2017.04.019_bib0105","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ijc.29698","article-title":"Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir","volume":"138","author":"Hui","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virusres.2017.04.019_bib0110","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/TCRM.S47434","article-title":"Therapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma","volume":"10","author":"Hutajulu","year":"2014","journal-title":"Ther. Clin. Risk Manage."},{"issue":"10","key":"10.1016\/j.virusres.2017.04.019_bib0115","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.4161\/cbt.7.10.6564","article-title":"Suppression of EBNA1 expression inhibits growth of EBV-positive NK\/T cell lymphoma cells","volume":"7","author":"Ian","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"20","key":"10.1016\/j.virusres.2017.04.019_bib0120","doi-asserted-by":"crossref","first-page":"11965","DOI":"10.1128\/JVI.01879-14","article-title":"Inactivation of the human papillomavirus E6 or E7 gene in cervical carcinoma cells by using a bacterial CRISPR\/Cas RNA-guided endonuclease","volume":"88","author":"Kennedy","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2017.04.019_bib0125","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.virol.2014.12.001","article-title":"Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR\/Cas RNA-guided DNA endonuclease","volume":"476","author":"Kennedy","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2017.04.019_bib0130","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.antiviral.2015.10.004","article-title":"Targeting hepatitis B virus cccDNA using CRISPR\/Cas9","volume":"123","author":"Kennedy","year":"2015","journal-title":"Antiviral Res."},{"issue":"7587","key":"10.1016\/j.virusres.2017.04.019_bib0135","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nature16526","article-title":"High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects","volume":"529","author":"Kleinstiver","year":"2016","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.virusres.2017.04.019_bib0140","doi-asserted-by":"crossref","first-page":"10662","DOI":"10.1128\/JVI.01665-14","article-title":"Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples","volume":"88","author":"Kwok","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virusres.2017.04.019_bib0145","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0092-8674(88)90530-2","article-title":"Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line","volume":"52","author":"Lawrence","year":"1988","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.virusres.2017.04.019_bib0150","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-3835(00)00353-0","article-title":"EBV DNA polymerase inhibition of tannins from Eugenia uniflora","volume":"154","author":"Lee","year":"2000","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.virusres.2017.04.019_bib0155","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijc.28007","article-title":"Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma","volume":"133","author":"Lei","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virusres.2017.04.019_bib0160","doi-asserted-by":"crossref","first-page":"e186","DOI":"10.1038\/mtna.2014.38","article-title":"The CRISPR\/Cas9 system facilitates clearance of the intrahepatic HBV templates In vivo","volume":"3","author":"Lin","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"8","key":"10.1016\/j.virusres.2017.04.019_bib0165","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1099\/vir.0.000159","article-title":"Inhibition of hepatitis B virus by the CRISPR\/Cas9 system via targeting the conserved regions of the viral genome","volume":"96","author":"Liu","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virusres.2017.04.019_bib0170","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/path.4025","article-title":"The pathological roles of BART miRNAs in nasopharyngeal carcinoma","volume":"227","author":"Lo","year":"2012","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.virusres.2017.04.019_bib0175","doi-asserted-by":"crossref","first-page":"e52426","DOI":"10.1371\/journal.pone.0052426","article-title":"CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma","volume":"7","author":"Lun","year":"2012","journal-title":"PLoS One"},{"issue":"R1","key":"10.1016\/j.virusres.2017.04.019_bib0180","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1093\/hmg\/ddv270","article-title":"Antigen-specific T cell therapies for cancer","volume":"24","author":"Manzo","year":"2015","journal-title":"Hum. Mol. Genet."},{"issue":"5","key":"10.1016\/j.virusres.2017.04.019_bib0185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/mp.53.5.248","article-title":"Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma","volume":"53","author":"Niedobitek","year":"2000","journal-title":"Mol. Pathol."},{"issue":"6","key":"10.1016\/j.virusres.2017.04.019_bib0190","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/0092-8674(86)90803-2","article-title":"The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation","volume":"47","author":"Raab-Traub","year":"1986","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.virusres.2017.04.019_bib0195","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1044579X0200086X","article-title":"Epstein-Barr virus in the pathogenesis of NPC","volume":"12","author":"Raab-Traub","year":"2002","journal-title":"Semin. Cancer Biol."},{"issue":"4","key":"10.1016\/j.virusres.2017.04.019_bib0200","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.coviro.2012.07.001","article-title":"Novel mechanisms of EBV-induced oncogenesis","volume":"2","author":"Raab-Traub","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"3","key":"10.1016\/j.virusres.2017.04.019_bib0205","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcv.2010.07.008","article-title":"Antiviral treatment for severe EBV infections in apparently immunocompetent patients","volume":"49","author":"Rafailidis","year":"2010","journal-title":"J. Clin. Virol."},{"issue":"11","key":"10.1016\/j.virusres.2017.04.019_bib0210","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/nprot.2013.143","article-title":"Genome engineering using the CRISPR-Cas9 system","volume":"8","author":"Ran","year":"2013","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.virusres.2017.04.019_bib0215","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/0092-8674(85)90282-X","article-title":"Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region","volume":"42","author":"Rawlins","year":"1985","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.virusres.2017.04.019_bib0220","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1128\/MCB.5.8.1822","article-title":"A putative origin of replication of plasmids derived from Epstein-Barr virus is composed of two cis-acting components","volume":"5","author":"Reisman","year":"1985","journal-title":"Mol. Cell. Biol."},{"issue":"6","key":"10.1016\/j.virusres.2017.04.019_bib0225","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative CT method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.virusres.2017.04.019_bib0230","doi-asserted-by":"crossref","first-page":"e216","DOI":"10.1038\/mtna.2014.68","article-title":"Targeting hepatitis B virus with CRISPR\/Cas9","volume":"3","author":"Seeger","year":"2014","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"25","key":"10.1016\/j.virusres.2017.04.019_bib0235","doi-asserted-by":"crossref","first-page":"10098","DOI":"10.1073\/pnas.1104144108","article-title":"Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence","volume":"108","author":"Semenova","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.virusres.2017.04.019_bib0240","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/biot.201400046","article-title":"CRISPR\/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox","volume":"9","author":"Senis","year":"2014","journal-title":"Biotechnol. J."},{"issue":"6166","key":"10.1016\/j.virusres.2017.04.019_bib0245","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","article-title":"Genome-scale CRISPR-Cas9 knockout screening in human cells","volume":"343","author":"Shalem","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.virusres.2017.04.019_bib0250","doi-asserted-by":"crossref","first-page":"14257","DOI":"10.1038\/ncomms14257","article-title":"Epstein-Barr virus particles induce centrosome amplification and chromosomal instability","volume":"8","author":"Shumilov","year":"2017","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.virusres.2017.04.019_bib0255","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/1087057110379154","article-title":"Development of a high-throughput screen for inhibitors of Epstein-Barr virus EBNA1","volume":"15","author":"Thompson","year":"2010","journal-title":"J. Biomol. Screen."},{"issue":"23","key":"10.1016\/j.virusres.2017.04.019_bib0260","doi-asserted-by":"crossref","first-page":"12362","DOI":"10.1128\/JVI.06059-11","article-title":"Epstein-Barr virus BamHI W repeat number limits EBNA2\/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains","volume":"85","author":"Tierney","year":"2011","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virusres.2017.04.019_bib0265","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.celrep.2013.09.012","article-title":"Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas","volume":"5","author":"Tsai","year":"2013","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.virusres.2017.04.019_bib0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/path.4448","article-title":"The role of Epstein-Barr virus in epithelial malignancies","volume":"235","author":"Tsao","year":"2015","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.virusres.2017.04.019_bib0275","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-9378-8-29","article-title":"Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1","volume":"8","author":"Tso","year":"2013","journal-title":"Infect. Agent Cancer"},{"issue":"6","key":"10.1016\/j.virusres.2017.04.019_bib0280","doi-asserted-by":"crossref","first-page":"e1005701","DOI":"10.1371\/journal.ppat.1005701","article-title":"CRISPR\/Cas9-mediated genome editing of herpesviruses limits productive and latent infections","volume":"12","author":"van Diemen","year":"2016","journal-title":"PLoS Pathog."},{"issue":"36","key":"10.1016\/j.virusres.2017.04.019_bib0285","doi-asserted-by":"crossref","first-page":"13157","DOI":"10.1073\/pnas.1410785111","article-title":"RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection","volume":"111","author":"Wang","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"3","key":"10.1016\/j.virusres.2017.04.019_bib0290","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/mt.2016.24","article-title":"CRISPR-Cas9 can inhibit HIV-1 replication but NHEJ repair facilitates virus escape","volume":"24","author":"Wang","year":"2016","journal-title":"Mol. Ther."},{"issue":"15","key":"10.1016\/j.virusres.2017.04.019_bib0295","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1128\/JVI.00588-12","article-title":"Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase \u03b7 recruitment to DNA damage sites","volume":"86","author":"Whitehurst","year":"2012","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.virusres.2017.04.019_bib0300","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1128\/JVI.03505-12","article-title":"Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase","volume":"87","author":"Whitehurst","year":"2013","journal-title":"J. Virol."},{"issue":"25","key":"10.1016\/j.virusres.2017.04.019_bib0305","doi-asserted-by":"crossref","first-page":"10092","DOI":"10.1073\/pnas.1102716108","article-title":"RNA-guided complex from a bacterial immune system enhances target recognition through seed sequence interactions","volume":"108","author":"Wiedenheft","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"6005","key":"10.1016\/j.virusres.2017.04.019_bib0310","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/313812a0","article-title":"Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells","volume":"313","author":"Yates","year":"1985","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.virusres.2017.04.019_bib0315","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.virol.2005.11.021","article-title":"siRNAs against the Epstein Barr virus latency replication factor, EBNA1, inhibit its function and growth of EBV-dependent tumor cells","volume":"346","author":"Yin","year":"2006","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virusres.2017.04.019_bib0320","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1044579X02000858","article-title":"Epidemiology of nasopharyngeal carcinoma","volume":"12","author":"Yu","year":"2002","journal-title":"Semin. Cancer Biol."},{"issue":"Pt. 3","key":"10.1016\/j.virusres.2017.04.019_bib0325","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1099\/jgv.0.000012","article-title":"CRISPR\/Cas9-mediated genome editing of Epstein-Barr virus in human cells","volume":"96","author":"Yuen","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"5","key":"10.1016\/j.virusres.2017.04.019_bib0330","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/gt.2015.2","article-title":"Harnessing the clustered regularly interspaced short palindromic repeat (CRISPR)\/CRISPR-associated Cas9 system to disrupt the hepatitis B virus","volume":"22","author":"Zhen","year":"2015","journal-title":"Gene Ther."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216308553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170216308553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T10:26:06Z","timestamp":1601979966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170216308553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":66,"alternative-id":["S0168170216308553"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2017.04.019","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suppression of Epstein-Barr virus DNA load in latently infected nasopharyngeal carcinoma cells by CRISPR\/Cas9","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2017.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}